Complete pathologic response of metastatic cutaneous squamous cell carcinoma and allograft rejection after treatment with combination immune checkpoint blockade
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-09-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512617301170 |
_version_ | 1819262623584092160 |
---|---|
author | David M. Miller, MD, PhD Beverly E. Faulkner-Jones, MD, PhD James R. Stone, MD, PhD Reed E. Drews, MD |
author_facet | David M. Miller, MD, PhD Beverly E. Faulkner-Jones, MD, PhD James R. Stone, MD, PhD Reed E. Drews, MD |
author_sort | David M. Miller, MD, PhD |
collection | DOAJ |
first_indexed | 2024-12-23T20:00:38Z |
format | Article |
id | doaj.art-e92699520dd04da2ad0274f5cdf8b490 |
institution | Directory Open Access Journal |
issn | 2352-5126 |
language | English |
last_indexed | 2024-12-23T20:00:38Z |
publishDate | 2017-09-01 |
publisher | Elsevier |
record_format | Article |
series | JAAD Case Reports |
spelling | doaj.art-e92699520dd04da2ad0274f5cdf8b4902022-12-21T17:33:06ZengElsevierJAAD Case Reports2352-51262017-09-013541241510.1016/j.jdcr.2017.06.005Complete pathologic response of metastatic cutaneous squamous cell carcinoma and allograft rejection after treatment with combination immune checkpoint blockadeDavid M. Miller, MD, PhD0Beverly E. Faulkner-Jones, MD, PhD1James R. Stone, MD, PhD2Reed E. Drews, MD3Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MassachusettsDepartment of Pathology, Beth Israel Deaconess Medical Center, Boston, MassachusettsDepartment of Pathology, Massachusetts General Hospital, Boston, MassachusettsDivision of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusettshttp://www.sciencedirect.com/science/article/pii/S2352512617301170immune checkpoint blockadeipilimumabnivolumabsquamous cell carcinoma |
spellingShingle | David M. Miller, MD, PhD Beverly E. Faulkner-Jones, MD, PhD James R. Stone, MD, PhD Reed E. Drews, MD Complete pathologic response of metastatic cutaneous squamous cell carcinoma and allograft rejection after treatment with combination immune checkpoint blockade JAAD Case Reports immune checkpoint blockade ipilimumab nivolumab squamous cell carcinoma |
title | Complete pathologic response of metastatic cutaneous squamous cell carcinoma and allograft rejection after treatment with combination immune checkpoint blockade |
title_full | Complete pathologic response of metastatic cutaneous squamous cell carcinoma and allograft rejection after treatment with combination immune checkpoint blockade |
title_fullStr | Complete pathologic response of metastatic cutaneous squamous cell carcinoma and allograft rejection after treatment with combination immune checkpoint blockade |
title_full_unstemmed | Complete pathologic response of metastatic cutaneous squamous cell carcinoma and allograft rejection after treatment with combination immune checkpoint blockade |
title_short | Complete pathologic response of metastatic cutaneous squamous cell carcinoma and allograft rejection after treatment with combination immune checkpoint blockade |
title_sort | complete pathologic response of metastatic cutaneous squamous cell carcinoma and allograft rejection after treatment with combination immune checkpoint blockade |
topic | immune checkpoint blockade ipilimumab nivolumab squamous cell carcinoma |
url | http://www.sciencedirect.com/science/article/pii/S2352512617301170 |
work_keys_str_mv | AT davidmmillermdphd completepathologicresponseofmetastaticcutaneoussquamouscellcarcinomaandallograftrejectionaftertreatmentwithcombinationimmunecheckpointblockade AT beverlyefaulknerjonesmdphd completepathologicresponseofmetastaticcutaneoussquamouscellcarcinomaandallograftrejectionaftertreatmentwithcombinationimmunecheckpointblockade AT jamesrstonemdphd completepathologicresponseofmetastaticcutaneoussquamouscellcarcinomaandallograftrejectionaftertreatmentwithcombinationimmunecheckpointblockade AT reededrewsmd completepathologicresponseofmetastaticcutaneoussquamouscellcarcinomaandallograftrejectionaftertreatmentwithcombinationimmunecheckpointblockade |